Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.

Original publication

DOI

10.1007/s11657-012-0070-7

Type

Journal article

Journal

Arch osteoporos

Publication Date

2012

Volume

7

Pages

25 - 30

Keywords

Antirheumatic Agents, Glucocorticoids, Humans, Osteoporosis, Rheumatic Diseases